December, 2016

article thumbnail

Taking health wearables to the next level – where is the market heading?

pharmaphorum

With rising healthcare costs, more informed and engaged patients, and advancing technology, health wearables have seen a significant uptake in recent years. However, the full potential of health wearables has yet to be recognised and there are still challenges to be resolved. What needs to be done on the regulatory, technical and healthcare side to take health wearables to the next level?

52
article thumbnail

Tumeric and Apixaban

Med Ed 101

Tumeric and Apixaban – Guest Post by Amanuel Tseggai A 72 year old man was newly diagnosed with atrial fibrillation and started on therapeutic dose of Enoxaparin after he was admitted to a hospital. Four days into his treatment with Enoxaparin his primary care provider decided to switch him to Apixaban- one of the newer oral […]. The post Tumeric and Apixaban appeared first on Med Ed 101.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Rifampin and Phenytoin Interaction

Med Ed 101

Drug interactions can make medication management challenging. Here’s a classic case demonstrating the rifampin and phenytoin interaction. A 47 year old patient with diabetes and seizure disorder is diagnosed with new onset osteomyelitis. The patient’s seizures were well controlled on phenytoin as they had not had one in well over a year.

article thumbnail

What Advantages Does Warfarin Have Over NOACS?

Med Ed 101

We all know the negatives of warfarin, but lets take a look at the advantages of warfarin. NOACs are gaining in popularity, no doubt about that. No matter which anticoagulant we are using, we must recognize that there are always positives and negatives. It is incredibly important to recognize those positives and negatives to best […]. The post What Advantages Does Warfarin Have Over NOACS?

40
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Selecting A Medication For Diabetic Neuropathy

Med Ed 101

Selecting a medication for diabetic neuropathy can be a bit challenging. You really need to weigh the adverse effect profile when choosing an agent. The case: A 55 year old male has a past medical history of diabetes. He has been experiencing tingling in his feet which hasn’t been too troublesome until lately. This has […]. The post Selecting A Medication For Diabetic Neuropathy appeared first on Med Ed 101.

article thumbnail

Recurrent Pneumonia and Frequent Antibiotic Use

Med Ed 101

GF is a 77 year old male with a past medical history of BPH, COPD, hypertension, constipation, Barrett’s esophagus, and anemia. Of late, he has had recurrent pneumonia episodes requiring frequent antibiotic use. He has had 3 courses of antibiotics within the last four months to treat pneumonia. His current medication list includes; Aspirin 81 […].

40
article thumbnail

Comparison of Warfarin and NOACS

Med Ed 101

You will find a comparison of warfarin and NOACS below. Both medication classes are frequently used in practice and a familiarity with these agents is necessary for any practicing pharmacist. A huge thank you to Aisha Shokoya for putting the majority of this table together. If you notice something that should be added or changed, please […].

40